ÂÜÀòÂÒÂ×

Mark King has more than 30 years of experience in life sciences and management consulting. Previously, Mr. King was president and founder of Back Bay Strategies and Kendall Strategies. Both were international life science consulting practices specialized in product development and commercial strategy, life cycle management, and branding. Mr. King and his partners sold Kendall Strategies to WPP Group plc in 1999.

Mr. King headed the commercial side of MGI Pharma where he acquired the company’s initial product portfolio and built an oncology sales and marketing organization.

At Bain & Company, Mr. King managed project teams working on business unit strategy, acquisitions and divestitures, cost reduction, and competitive strategy for clients in the information services, textile, steel, and chemical industries. At Baxter International, Mr. King helped reposition its plasma derivatives business and launch its total parenteral nutrition product line in Europe.

Mr. King holds an MBA with distinction from the Harvard Business School and an A.B. with honors in Economics and Chemistry from the University of North Carolina.